Prospective assessment of donor blood screening for antibody to hepatitis C virus by first- and second-generation assays as a means of preventing posttransfusion hepatitis

Hepatology

Volumn 23, Issue 4, 1996, Pages 708-712

  Takano, Susumu ^a   Nakamura, Kozo ^a   Kawai, Shigenobu ^b   Yokosuka, Osamu ^b   Satomura, Yoichi ^c   Omata, Masao ^d  

^a KAWASAKI MUNICIPAL HOSPITAL   (Japan)

^b CHIBA UNIVERSITY   (Japan)

^c CHIBA UNIVERSITY HOSPITAL   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY;

ADULT; AGED; ANTIBODY TITER; ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; CHILD; DISEASE COURSE; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; PRIORITY JOURNAL; PROSPECTIVE STUDY; VIRUS DETECTION;

ADULT; AGED; AGED, 80 AND OVER; BLOOD DONORS; BLOOD TRANSFUSION; CHILD; CHILD, PRESCHOOL; FEMALE; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 0029937867     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510230408     Document Type: Article

References (25)

1. Alter HJ, Holland PV, Purcell RH, Lander JL, Feinstone SM, Morrow AG, Schmidt PJ. Post-transfusion hepatitis after exclusion of commercial and hepatitis-B antigen-positive donors. Ann Intern Med 1972;77:691-699.
2. Dienstag JL, Feinstone SM, Purcell RH, Wong DC, Alter HJ, Holland PV. Non-A, non-B post-transfusion hepatitis. Lancet 1977;1:560-562.
3. Tateda A, Kikuchi K, Numazaki Y, Shirachi R, Ishida N. Non-B hepatitis in Japanese recipients of blood transfusions: clinical and serologic studies after the introduction of laboratory screening of donor blood for hepatitis B surface antigen. J Infect Dis 1979;139:511-518.
4. Koretz RL, Stone O, Gitnick GL. The long-term course of non-A, non-B post-transfusion hepatitis. Gastroenterology 1979;79:893-898.
5. Gilliam JH, Geisinger KR, Richter JE. Primary hepatocellular carcinoma after chronic non-A, non-B post-transfusion hepatitis. Ann Intern Med 1984;101:794-795.
6. Kiyosawa K, Akahane Y, Nagata A, Furuta S. Hepatocellular carcinoma after non-A, non-B post-transfusion hepatitis. Am J Gastroenterol 1984;79:777-781.
7. Takano S, Omata M, Ohto M, Satomura Y. Prospective assessment of donor blood screening for antibody to hepatitis C virus and high-titer antibody to hepatitis B core antigen as a means of preventing post-transfusion hepatitis. HEPATOLOGY 1993;18: 235-239.
8. Takano S, Omata M, Ohto M, Satomura Y. Post-transfusion hepatitis in Japan. Vox Sang 1992;62:156-164.
9. Izuka H, Ohmura K, Ishijima A, Satoh K, Tanaka T, Tsuda F, Okamoto H, et al. Correlation between anti-HBc titers and HBV DNA in blood units without detectable HBsAg. Vox Sang 1992; 63:107-111.
10. Kuo G, Choo QL, Alter HJ, Gitnick GL, Redeker AG, Purcell RH, Miyamura T, et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989;244:362-364.
11. Aach RD, Stevens CE, Hollinger FB, Mosely JW, Peterson DA, Taylor PE, Johnson RG, et al. Hepatitis C virus infection in post-transfusion hepatitis. An assay with first- and second-generation assays. N Engl J Med 1991;325:1325-1329.
12. Aach RD, Szmuness W, Mosley JW, Hollinger FB, Kahn RA, Stevens CE, Edwards VM, et al. Serum alanine aminotransferase of donors in relations to the risk of non-A, non-B hepatitis in recipients. N Engl J Med 1981;304:969-994.
13. Alter HJ, Purcell RH, Holland PV, Ailing DW, Koziol DE. Donor transaminase and recipient hepatitis. JAMA 1981;246:630-634.
14. Stevens CE, Aach RD, Hollinger FB, Mosley JW, Szmuness W, Kahn R, Werch J, et al. Hepatitis B virus antibody in blood donors and the occurrence of non-A, non-B hepatitis in transfusion recipients. Ann Intern Med 1984;101:733-738.
15. Koziol DE, Holland PV, Alling DW, Melpolder JC, Solomon RE, Purcell RH, Hudson LM, et al. Antibody to hepatitis B core antigen as a paradoxical marker for non-A, non-B hepatitis agents in donated blood. Ann Intern Med 1986;104:488-495.
16. Kline WE, Bowman RJ, McCurdy E, O'Malley JP, Sandler SG. Hepatitis B core antibody (anti-HBc) in blood donors in the United States: implications for surrogate testing programs. Transfusion 1987;27:99-102.
17. Hanson MR, Polesky HF. Evaluation of routine anti-HBc screening of volunteer blood donors: a questionable surrogate test for non-A, non-B hepatitis. Transfusion 1987;27:107-108.
18. Hoyos M, Sarrion JV, Perez-Castellanos T, Prieto M, Marty ML, Garrigues V, Berenguer J. Prospective assessment of donor blood screening for antibody to hepatitis B core antigen as a means of preventing post-transfusion non-A, non-B hepatitis. HEPATOLOGY 1989;9:449-451.
19. Ito S, Tsuji Y, Kitagawa N, Ishihara A, Syundo J, Tamura Y, Kishi S, et al. Clinical value of the guanase screening test in donor blood for prevention of post-transfusion non-A, non-B hepatitis. HEPATOLOGY 1988;8:383-384.
20. Japan Red Cross Non-A, Non-B Hepatitis Research Group. Effect of screening for hepatitis C virus antibody and hepatitis B virus core antibody on incidence of post-transfusion hepatitis. Lancet 1991;338:1040-1041.
21. Seeff LB, Zimmerman HJ, Wright EC, Finkelstein JD, Garcia-Pont P, Greenlee HB, Dietz AA, et al. Randomized, double-blind controlled trial of the efficacy of immune serum globulin for the prevention of post-transfusion hepatitis. Gastroenterology 1977; 72:111-121.
22. Conrad ME, Knodell RG, Bradley EL, Flannery EP, Ginsberg AL. Risk factors in transmission of non-A, non-B post-transfusion hepatitis. Transfusion 1977;17:579-585.
23. Donahue JG, Munoz A, Ness DM, Brown DE, Yawn DH, McAllister HA, Reitz BA, et al. The declining risk of post-transfusion hepatitis C virus infection. N Engl J Med 1992;327:369-373.
24. Kato N, Yokosuka O, Omata M, Hosoda K, Ohto M. Detection of hepatitis C virus ribonucleic acid in the serum by amplification with polymerase chain reaction. J Clin Invest 1990;86:1764-1767.
25. Hosoda K, Yokosuka O, Omata M, Kato N, Ohto M. Detection and partial sequences of hepatitis C virus RNA in the liver. Gastroenterology 1991;101:766-771.